238 related articles for article (PubMed ID: 1375224)
41. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
42. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor.
Batzer AG; Blaikie P; Nelson K; Schlessinger J; Margolis B
Mol Cell Biol; 1995 Aug; 15(8):4403-9. PubMed ID: 7542744
[TBL] [Abstract][Full Text] [Related]
43. Characterization, partial purification, and peptide sequencing of p130,the main phosphoprotein associated with v-Crk oncoprotein.
Sakai R; Iwamatsu A; Hirano N; Ogawa S; Tanaka T; Nishida J; Yazaki Y; Hirai H
J Biol Chem; 1994 Dec; 269(52):32740-6. PubMed ID: 7806494
[TBL] [Abstract][Full Text] [Related]
44. An oncogenic epidermal growth factor receptor signals via a p21-activated kinase-caldesmon-myosin phosphotyrosine complex.
McManus MJ; Boerner JL; Danielsen AJ; Wang Z; Matsumura F; Maihle NJ
J Biol Chem; 2000 Nov; 275(45):35328-34. PubMed ID: 10954714
[TBL] [Abstract][Full Text] [Related]
45. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
Ellis C; Moran M; McCormick F; Pawson T
Nature; 1990 Jan; 343(6256):377-81. PubMed ID: 1689011
[TBL] [Abstract][Full Text] [Related]
46. Sequence specificity in recognition of the epidermal growth factor receptor by protein tyrosine phosphatase 1B.
Milarski KL; Zhu G; Pearl CG; McNamara DJ; Dobrusin EM; MacLean D; Thieme-Sefler A; Zhang ZY; Sawyer T; Decker SJ
J Biol Chem; 1993 Nov; 268(31):23634-9. PubMed ID: 7693694
[TBL] [Abstract][Full Text] [Related]
47. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
[TBL] [Abstract][Full Text] [Related]
48. Kinetics of p56lck and p60src Src homology 2 domain binding to tyrosine-phosphorylated peptides determined by a competition assay or surface plasmon resonance.
Payne G; Shoelson SE; Gish GD; Pawson T; Walsh CT
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4902-6. PubMed ID: 7685110
[TBL] [Abstract][Full Text] [Related]
49. Activation of c-Src in cells bearing v-Crk and its suppression by Csk.
Sabe H; Okada M; Nakagawa H; Hanafusa H
Mol Cell Biol; 1992 Oct; 12(10):4706-13. PubMed ID: 1383688
[TBL] [Abstract][Full Text] [Related]
50. Crk interacts with tyrosine-phosphorylated p116 upon T cell activation.
Sawasdikosol S; Ravichandran KS; Lee KK; Chang JH; Burakoff SJ
J Biol Chem; 1995 Feb; 270(7):2893-6. PubMed ID: 7531694
[TBL] [Abstract][Full Text] [Related]
51. Phosphorylation of the ras GTPase-activating protein (GAP) by the p93c-fes protein-tyrosine kinase in vitro and formation of GAP-fes complexes via an SH2 domain-dependent mechanism.
Hjermstad SJ; Briggs SD; Smithgall TE
Biochemistry; 1993 Oct; 32(39):10519-25. PubMed ID: 7691175
[TBL] [Abstract][Full Text] [Related]
52. Raf-1 interacts with Fyn and Src in a non-phosphotyrosine-dependent manner.
Cleghon V; Morrison DK
J Biol Chem; 1994 Jul; 269(26):17749-55. PubMed ID: 7517401
[TBL] [Abstract][Full Text] [Related]
53. The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R.
Schumacher C; Knudsen BS; Ohuchi T; Di Fiore PP; Glassman RH; Hanafusa H
J Biol Chem; 1995 Jun; 270(25):15341-7. PubMed ID: 7797522
[TBL] [Abstract][Full Text] [Related]
54. The SH2 and SH3 domains of pp60src direct stable association with tyrosine phosphorylated proteins p130 and p110.
Kanner SB; Reynolds AB; Wang HC; Vines RR; Parsons JT
EMBO J; 1991 Jul; 10(7):1689-98. PubMed ID: 1710979
[TBL] [Abstract][Full Text] [Related]
55. c-Cbl is inducibly tyrosine-phosphorylated by epidermal growth factor stimulation in fibroblasts, and constitutively tyrosine-phosphorylated and associated with v-Src in v-src-transformed fibroblasts.
Odai H; Sasaki K; Hanazono Y; Ueno H; Tanaka T; Miyagawa K; Mitani K; Yazaki Y; Hirai H
Jpn J Cancer Res; 1995 Dec; 86(12):1119-26. PubMed ID: 8635998
[TBL] [Abstract][Full Text] [Related]
56. Src homology 2 domains enhance tyrosine phosphorylation
Jadwin JA; Curran TG; Lafontaine AT; White FM; Mayer BJ
J Biol Chem; 2018 Jan; 293(2):623-637. PubMed ID: 29162725
[TBL] [Abstract][Full Text] [Related]
57. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
58. Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1.
Larose L; Gish G; Shoelson S; Pawson T
Oncogene; 1993 Sep; 8(9):2493-9. PubMed ID: 7689724
[TBL] [Abstract][Full Text] [Related]
59. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk.
Knudsen BS; Feller SM; Hanafusa H
J Biol Chem; 1994 Dec; 269(52):32781-7. PubMed ID: 7806500
[TBL] [Abstract][Full Text] [Related]
60. v-Crk modulation of growth factor-induced PC12 cell differentiation involves the Src homology 2 domain of v-Crk and sustained activation of the Ras/mitogen-activated protein kinase pathway.
Teng KK; Lander H; Fajardo JE; Hanafusa H; Hempstead BL; Birge RB
J Biol Chem; 1995 Sep; 270(35):20677-85. PubMed ID: 7657647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
